RET testing for inherited MEN2 risk

Germline RET mutation analysis for MEN2 susceptibility; no complete variant inventory, tumor-somatic analysis, proven cancer diagnosis or treatment benefit is asserted. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.